Medivir AB – Trademark Portfolio

Entity Type: 99

Medivir AB holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include XERESE. The owner is based in 111 48 Stockholm.

Blasieholmsgatan 2

111 48 Stockholm , SE

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEDIVIR
MEDIVIR
Cancelled 2014
XERESE
XERESE
Registered 2010
XERCLEAR
XERCLEAR
Cancelled 2009
LIPSOVIR
LIPSOVIR
Cancelled 2004

Trademark Classifications

Medivir AB's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Medivir AB have?

Medivir AB has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does Medivir AB file in?

Medivir AB files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Medivir AB's most well-known trademarks?

Medivir AB's registered trademark portfolio includes well-known marks such as XERESE. These are among 1 currently registered trademark in the portfolio.

What is Medivir AB's trademark registration success rate?

Medivir AB has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.